PATIENTS' PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

被引：1
|
作者：
Zeidan, A. [1 ]
Perepezko, K. [2 ]
Salimi, T. [3 ]
Washington, T. [3 ]
Epstein, R. [4 ]
机构：
[1] Yale Canc Ctr, Hematol, New Haven, CT USA
[2] CorEvitas Llc, Waltham, MA USA
[3] Taiho Oncol Inc, Princeton, NJ USA
[4] Epstein Hlth Llc, Woodcliff Lake, NJ USA
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O14
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Oral decitabine plus cedazuridine versus intravenous decitabine
    de Witte, Theo
    LANCET HAEMATOLOGY, 2024, 11 (01): : e2 - e3
  • [12] DEMOGRAPHIC AND CLINICAL CHARACTERISTICS AMONG PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING ORAL DECITABINE AND CEDAZURIDINE OR INTRAVENOUS/SUBCUTANEOUS HYPOMETHYLATING AGENTS IN A REAL-WORLD SETTING
    Zeidan, A.
    Martin, A.
    Costantino, H.
    Modi, K.
    Salimi, T.
    Washington, T.
    Epstein, R.
    LEUKEMIA RESEARCH, 2023, 128
  • [13] Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
    Garcia-Manero, Guillermo
    McCloskey, James
    Griffiths, Elizabeth A.
    Yee, Karen W. L.
    Zeidan, Amer M.
    Al-Kali, Aref
    Deeg, H. Joachim
    Patel, Prapti A.
    Sabloff, Mitchell
    Keating, Mary-Margaret
    Zhu, Nancy
    Gabrail, Nashat Y.
    Fazal, Salman
    Maly, Joseph
    Odenike, Olatoyosi
    Kantarjian, Hagop
    DeZern, Amy E.
    O'Connell, Casey L.
    Roboz, Gail J.
    Busque, Lambert
    Buckstein, Rena
    Amin, Harshad
    Randhawa, Jasleen
    Leber, Brian
    Shastri, Aditi
    Dao, Kim-Hien
    Oganesian, Aram
    Hao, Yong
    Keer, Harold N.
    Azab, Mohammad
    Savona, Michael R.
    LANCET HAEMATOLOGY, 2024, 11 (01): : e15 - e26
  • [14] Decitabine in myelodysplastic syndromes
    Saba, HI
    Wijermans, PW
    SEMINARS IN HEMATOLOGY, 2005, 42 (03) : S23 - S31
  • [15] Decitabine in myelodysplastic syndromes
    Saba, Hussain
    DRUGS, 2006, 66 (07) : 960 - 960
  • [16] DECITABINE IN TREATMENT OF PATIENTS WITH INTERMEDIATEOR HIGH-RISK MYELODYSPLASTIC SYNDROMES
    Kalinichenko, E.
    Ponteleeva, I.
    Fiodarava, A.
    Iskrov, I.
    Uss, A.
    LEUKEMIA RESEARCH, 2017, 55 : S71 - S72
  • [17] Spotlight on decitabine for myelodysplastic syndromes in Chinese patients
    Jing, Yu
    Shen, Xue
    Mei, Qian
    Han, Weidong
    ONCOTARGETS AND THERAPY, 2015, 8 : 2783 - 2790
  • [18] Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study
    Bataller, Alex
    Sasaki, Koji
    Urrutia, Samuel
    Montalban-Bravo, Guillermo
    Bazinet, Alexandre
    Chien, Kelly
    Hammond, Danielle
    Bouligny, Ian M.
    Swaminathan, Mahesh
    Issa, Ghayas
    Short, Nicholas
    Daver, Naval
    DiNardo, Courtney D.
    Kadia, Tapan
    Jabbour, Elias
    Ravandi, Farhad
    Roboz, Gail J.
    Savona, Michael
    Griffiths, Elizabeth A.
    McCloskey, James
    Odenike, Olatoyosi
    Oganesian, Aram
    Keer, Harold N.
    Azab, Mohammad
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [19] Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
    Bataller, Alex
    Montalban-Bravo, Guillermo
    Bazinet, Alexandre
    Alvarado, Yesid
    Chien, Kelly
    Venugopal, Sangeetha
    Ishizawa, Jo
    Hammond, Danielle
    Swaminathan, Mahesh
    Sasaki, Koji
    Issa, Ghayas C.
    Short, Nicholas J.
    Masarova, Lucia
    Daver, Naval G.
    Kadia, Tapan M.
    Colla, Simona
    Qiao, Wei
    Huang, Xuelin
    Kanagal-Shamanna, Rashmi
    Hendrickson, Stephany
    Ravandi, Farhad
    Jabbour, Elias
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    LANCET HAEMATOLOGY, 2024, 11 (03): : e186 - e195
  • [20] An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
    Garcia, Jacqueline S.
    Jain, Nitin
    Godley, Lucy A.
    ONCOTARGETS AND THERAPY, 2010, 3 : 1 - 13
12345